Peter Hon, MD
Surgery · New York, NYNPI 1487894382
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $813 of the $1,265 with a category attached, or 64.2%. Medtronic accounts for 65.7% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $855 and has fallen 90.4% since, to $83 in 2025. That places this record below the midpoint for surgery clinicians in NY, where the typical reported total is $1,254.
Across 10 payments — averaging $126.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$831
- Davol Inc.$207
- TELA Bio, Inc.$121
- Pylant Medical$27
- THD America, Inc.$20
- Boston Scientific$17
- plus $43 from 3 others
What the payments were for
- Consulting fees$81364%
- Food & beverage$45336%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 2 | $831 |
| Davol Inc. | 1 | $207 |
| TELA Bio, Inc. | 1 | $121 |
| Pylant Medical | 1 | $27 |
| THD America, Inc. | 1 | $20 |
| Boston Scientific | 1 | $17 |
| AbbVie | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VersaOne$813
- Phasix Mesh$207
- OviTex 2S$121
How this compares
$1,265 in reported general payments places this provider in the 50th percentile of 1,596 surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgery in New York
- Cheguevara AfanehNew York$1.4M
- Flavio Malcher Martins de OliveiraNew York$695K
- Yuri NovitskyNew York$548K
- Rasa ZarnegarNew York$478K
- Tanuja DamaniNew York$459K
- Rache SimmonsNew York$371K
- Marina KurianNew York$328K
- Megan JenkinsNew York$290K
- Brian JacobNew York$225K
- Robin BlackstoneNew York$174K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.